| Long-term use of ticagrelor in patients with prior myocardial infarction PTSC Investigators N Engl J Med 372 (19), 1791-800, 2015 | 2169* | 2015 |
| Carotid intima-media thickness progression as surrogate marker for cardiovascular risk: meta-analysis of 119 clinical trials involving 100 667 patients P Willeit, L Tschiderer, E Allara, K Reuber, L Seekircher, LU Gao, X Liao, ... Circulation 142 (7), 621-642, 2020 | 313 | 2020 |
| Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC) AJ Vallejo-Vaz, CAT Stevens, ARM Lyons, KI Dharmayat, T Freiberger, ... The Lancet 398 (10312), 1713-1725, 2021 | 188 | 2021 |
| Effect of specific lipoprotein (a) apheresis on coronary atherosclerosis regression assessed by quantitative coronary angiography MS Safarova, MV Ezhov, OI Afanasieva, YG Matchin, RV Atanesyan, ... Atherosclerosis Supplements 14 (1), 93-99, 2013 | 139 | 2013 |
| Rapid identification of familial hypercholesterolemia from electronic health records: the SEARCH study MS Safarova, H Liu, IJ Kullo Journal of clinical lipidology 10 (5), 1230-1239, 2016 | 101 | 2016 |
| The effects of vitamin D supplementation and 25-hydroxyvitamin D levels on the risk of myocardial infarction and mortality P Acharya, T Dalia, S Ranka, P Sethi, OA Oni, MS Safarova, D Parashara, ... Journal of the Endocrine Society 5 (10), bvab124, 2021 | 74 | 2021 |
| Lipoprotein (a) level and apolipoprotein (a) phenotype as predictors of long-term cardiovascular outcomes after coronary artery bypass grafting MV Ezhov, MS Safarova, OI Afanasieva, VV Kukharchuk, SN Pokrovsky Atherosclerosis 235 (2), 477-482, 2014 | 62 | 2014 |
| Matrix metalloproteinase 9 as a predictor of coronary atherosclerotic plaque instability in stable coronary heart disease patients with elevated lipoprotein (a) levels M Ezhov, M Safarova, O Afanasieva, M Mitroshkin, Y Matchin, ... Biomolecules 9 (4), 129, 2019 | 54 | 2019 |
| My approach to the patient with familial hypercholesterolemia MS Safarova, IJ Kullo Mayo Clinic Proceedings 91 (6), 770-786, 2016 | 52 | 2016 |
| Specific Lp (a) apheresis: A tool to prove lipoprotein (a) atherogenicity SN Pokrovsky, OI Afanasieva, MS Safarova, TV Balakhonova, YG Matchin, ... Atherosclerosis Supplements 30, 166-173, 2017 | 51 | 2017 |
| Normative values for carotid intima media thickness and its progression: Are they transferrable outside of their cohort of origin? X Liao, GD Norata, JF Polak, CDA Stehouwer, A Catapano, T Rundek, ... European journal of preventive cardiology 23 (11), 1165-1173, 2016 | 45 | 2016 |
| The Return of Actionable Variants Empirical (RAVE) Study, a Mayo Clinic genomic medicine implementation study: design and initial results IJ Kullo, J Olson, X Fan, M Jose, M Safarova, CR Breitkopf, E Winkler, ... Mayo Clinic Proceedings 93 (11), 1600-1610, 2018 | 34 | 2018 |
| PROG-IMT and the Proof-ATHERO Study Groups. Carotid intima-media thickness progression as surrogate marker for cardiovascular risk: meta-analysis of 119 clinical trials … P Willeit, L Tschiderer, E Allara, K Reuber, L Seekircher, L Gao, X Liao, ... Circulation 142 (7), 621-642, 2020 | 33 | 2020 |
| Genetic basis of hypercholesterolemia in adults S Saadatagah, M Jose, O Dikilitas, L Alhalabi, AA Miller, X Fan, JE Olson, ... NPJ genomic medicine 6 (1), 28, 2021 | 30 | 2021 |
| Specific Lipoprotein (a) apheresis attenuates progression of carotid intima-media thickness in coronary heart disease patients with high lipoprotein (a) levels MV Ezhov, MS Safarova, OI Afanasieva, OA Pogorelova, MI Tripoten, ... Atherosclerosis Supplements 18, 163-169, 2015 | 30 | 2015 |
| A phenome-wide association study to discover pleiotropic effects of PCSK9, APOB, and LDLR MS Safarova, BA Satterfield, X Fan, EE Austin, Z Ye, L Bastarache, ... NPJ Genomic Medicine 4 (1), 3, 2019 | 27 | 2019 |
| Lowering of lipoprotein (a) level under niacin treatment is dependent on apolipoprotein (a) phenotype NV Artemeva, MS Safarova, MV Ezhov, OI Afanasieva, OA Dmitrieva, ... Atherosclerosis Supplements 18, 53-58, 2015 | 25 | 2015 |
| A clinical decision support tool for familial hypercholesterolemia based on physician input AA Hasnie, A Kumbamu, MS Safarova, PJ Caraballo, IJ Kullo Mayo Clinic Proceedings: Innovations, Quality & Outcomes 2 (2), 103-112, 2018 | 23 | 2018 |
| Associations of genetically predicted Lp (a)(lipoprotein [a]) levels with cardiovascular traits in individuals of European and African Ancestry BA Satterfield, O Dikilitas, MS Safarova, SL Clarke, C Tcheandjieu, X Zhu, ... Circulation: Genomic and Precision Medicine 14 (4), e003354, 2021 | 22 | 2021 |
| Association of lipoprotein (a) level with short-and long-term outcomes after CABG: The role of lipoprotein apheresis MV Ezhov, OI Afanasieva, LN Il'ina, MS Safarova, IY Adamova, ... Atherosclerosis Supplements 30, 187-192, 2017 | 21 | 2017 |
